Marshall Wace, LLP Outset Medical, Inc. Transaction History
Marshall Wace, LLP
- $63.3 Billion
- Q1 2024
A detailed history of Marshall Wace, LLP transactions in Outset Medical, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 53,447 shares of OM stock, worth $205,770. This represents 0.0% of its overall portfolio holdings.
Number of Shares
53,447
Previous 20,235
164.13%
Holding current value
$205,770
Previous $109,000
8.26%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding OM
# of Institutions
122Shares Held
41MCall Options Held
63.4KPut Options Held
32.1K-
Ameriprise Financial Inc Minneapolis, MN5.11MShares$19.7 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.01MShares$15.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$12.6 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY3.11MShares$12 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.89MShares$11.1 Million0.0% of portfolio
About Outset Medical, Inc.
- Ticker OM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 48,007,300
- Market Cap $185M
- Description
- Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...